These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 18617225

  • 1. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function.
    Gresele P, Migliacci R, Vedovati MC, Ruffatti A, Becattini C, Facco M, Guglielmini G, Boscaro E, Mezzasoma AM, Momi S, Pengo V.
    Thromb Res; 2009; 123(3):444-51. PubMed ID: 18617225
    [Abstract] [Full Text] [Related]

  • 2. Patients with antiphospholipid syndrome display endothelial perturbation.
    Cugno M, Borghi MO, Lonati LM, Ghiadoni L, Gerosa M, Grossi C, De Angelis V, Magnaghi G, Tincani A, Mari D, Riboldi P, Meroni PL.
    J Autoimmun; 2010 Mar; 34(2):105-10. PubMed ID: 19656656
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R, Falcinelli F, Imperiali P, Floridi A, Nenci GG, Gresele P.
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
    Jy W, Tiede M, Bidot CJ, Horstman LL, Jimenez JJ, Chirinos J, Ahn YS.
    Thromb Res; 2007 May; 121(3):319-25. PubMed ID: 17582471
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B, Chong AY, Nuttall S, Lip GY.
    Thromb Res; 2008 May; 122(1):85-90. PubMed ID: 17996280
    [Abstract] [Full Text] [Related]

  • 10. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P.
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory response and the endothelium.
    Meroni PL, Borghi MO, Raschi E, Ventura D, Sarzi Puttini PC, Atzeni F, Lonati L, Parati G, Tincani A, Mari D, Tedesco F.
    Thromb Res; 2004 Mar; 114(5-6):329-34. PubMed ID: 15507262
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F, Spinelli FR, Alessandri C, Pacelli M, Ceccarelli F, Marocchi E, Montali A, Capozzi A, Buttari B, Profumo E, Sorice M, Arca M, Valesini G, Riganò R.
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [Abstract] [Full Text] [Related]

  • 14. Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndrome.
    Walenga JM, Michal K, Hoppensteadt D, Wood JJ, Robinson JA, Bick RL.
    Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S76-84. PubMed ID: 10726041
    [Abstract] [Full Text] [Related]

  • 15. Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.
    Stanisavljevic N, Stojanovich L, Marisavljevic D, Djokovic A, Dopsaj V, Kotur-Stevuljevic J, Martinovic J, Memon L, Radovanovic S, Todic B, Lisulov D.
    Clin Rheumatol; 2016 Oct; 35(10):2485-93. PubMed ID: 27562033
    [Abstract] [Full Text] [Related]

  • 16. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation.
    Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA.
    Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1245-9. PubMed ID: 12763762
    [Abstract] [Full Text] [Related]

  • 17. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
    Sorensen MB, Franks S, Robertson C, Pennell DJ, Collins P.
    Clin Endocrinol (Oxf); 2006 Nov 01; 65(5):655-9. PubMed ID: 17054469
    [Abstract] [Full Text] [Related]

  • 18. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM, Seredavkina nV, Mach ES, Aleksandrova EN, Novikov AA, Cherkasova MV, Nasonov EL.
    Ter Arkh; 2008 Nov 01; 80(10):60-7. PubMed ID: 19105418
    [Abstract] [Full Text] [Related]

  • 19. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
    Lanes R, Marcano H, Villaroel O, Gunczler P, Morillo E, Paoli M, Perez M, Maulino N, Palacios A.
    Horm Res; 2008 Nov 01; 70(4):230-5. PubMed ID: 18772596
    [Abstract] [Full Text] [Related]

  • 20. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F, Cella G, Casonato A, Ermani M, Vettor R, Zanella S, Lumachi F.
    Horm Metab Res; 2006 Feb 01; 38(2):125-9. PubMed ID: 16523414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.